Search Results
May 14, 2026, 08:30 ET Veteran Owned Carbliss Turns New Americana Launch Into Giving Back to Veterans with Missions of Honor
support the Carbliss brand. "Supporting veterans through Missions of Honor aligns perfectly with the mission behind CarblissCares," quoted Saylor Salm, Committee Founder. "As a veteran owned company, this campaign is especially meaningful to us."Consumers can support the initiative by looking
More news about: Carbliss Premium Hand Crafted Cocktails
May 12, 2026, 22:11 ET Shareholder Alert: Ademi LLP investigates whether Salem Media Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, May 12, 2026 /PRNewswire/ -- Ademi LLP is investigating Salem (OTCQX: SALM) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with WaterStone.
More news about: Ademi LLP
Apr 20, 2026, 16:23 ET Psilera Commends Landmark Executive Order Prioritizing Psychedelic Therapies
2nd Annual Neuroscience Innovation Partnering and Licensing SummitCo-Founder and Chief Scientific Officer Dr. Jackie von Salm, speaking on panel.6/10/26
More news about: Psilera
Feb 24, 2026, 09:07 ET Tully Luxury Travel Announces Modernized Vision and Leadership Expansion, Defining Its Next Chapter in Experiential Luxury
Central to this evolution is Chief Operating Officer Steven Salm, whose appointment signals a strategic commitment to technology-enabled service, hospitality-driven operational excellence, and the preservation of the
More news about: Tully Luxury Travel
Oct 02, 2025, 15:40 ET Psilera Inc. Secures National Institutes of Health Grant for AUD Research
"We are thankful to the NIH for this funding which will enable us to quickly advance our research into AUD," said Dr. Jackie von Salm, Co-founder and CSO of Psilera. "Neuroplastogens hold tremendous promise in treating a range of devastating and debilitating diseases, and this endorsement
More news about: Psilera Inc.
Sep 04, 2025, 08:15 ET Healthcare Industry Veteran Scott Rairigh Joins Psilera to Lead Corporate Development
allows me to serve patients and families more meaningfully," said Rairigh. "Since joining the Board in 2019, I have been thoroughly impressed by Dr. von Salm, Dr. Witowski, and the entire Psilera team. Their commitment to delivering first-in-class medicines that rewire and activate neuronal pathways targeting
More news about: Psilera, Inc.
Jun 09, 2025, 08:05 ET Psilera Collaborates with Drug Development Leader Hesperos to Advance Preclinical Modeling of PSIL-006 for Frontotemporal Dementia
a significant step forward in our mission to develop new treatments for neurodegenerative diseases," said Dr. Jackie von Salm, Co-Founder and Chief Scientific Officer of Psilera. "Utilizing their cutting-edge platform allows us to gain deeper insights into PSIL-006's mechanism
More news about: Psilera, Inc